Lee et al. [112] demonstrated that EGFR-TKI-resistant lung adenocarcinoma and SCLC tissues share a common clonal origin and undergo branching evolution, as revealed through analysis of both tissue types. This evidence concerns the gene EGFR and lung adenocarcinoma.